Genflow Biosciences PLC (GENF)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.95p
Buy
1.05p
0.0655p (+7.28%)
Prices updated at 12 May 2025, 17:15 BST
| Prices minimum 15 mins delay
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Ms. Tamara L. Joseph
CEO
Dr. Eric J. Leire
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
-
Head office
6 Heddon Street
London
United Kingdom
W1B 4BT
Key personnel
Owner name | Salary |
|---|---|
Ms. Tamara L. Joseph Non-Executive Director, Chairman | - |
Dr. Yassine Bendiabdallah Non-Executive Director | - |
Dr. Peter King-Lewis Non-Executive Director | - |
Dr. Guy-Charles Fanneau de la Horie Non-Executive Director | - |
Dr. Eric J. Leire Executive Director, Chief Executive Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Miton UK Microcap | 16,000,000 |
| Miton Asset Management Limited | 4,611,262 |
| Premier Miton UK Smaller Companies | 4,611,262 |
Director dealings
Date | Action |
|---|---|
| 27 Mar 2025 | Purchase |
Please note that past performance is not a reliable indicator of future returns.
